Categories AlphaGraphs, Earnings, Technology

CenturyLink, Inc. (NYSE: CTL): Q2 earnings highlights

Centurylink (NYSE: CTL) reported second-quarter financial results after the regular trading hours on Wednesday.  Both revenue and EPS for the quarter came in better than the Wall Street projections.

CTL shares rose 4.6% immediately following the announcement. The stock has declined 31% so far this year.

centurylink Q2 2020 eanrings

Looking forward to listening to management/ analyst comments on Q2 results? Stay tuned here for Centurylink Q2 2020 earnings call transcript

CFO Neel Dev said, “We are lowering our interest expense outlook for the year by about $100 million, driven by progress on our deleveraging and refinancing initiatives along with a low-interest-rate environment.”

Prior performance

[irp posts=”68388″]

______

Most Popular

Key takeaways from JM Smucker’s (SJM) Q4 2025 earnings report

Shares of The J.M. Smucker Co. (NYSE: SJM) plunged 15% on Tuesday after the company delivered mixed results for the fourth quarter of 2025. While earnings came ahead of expectations,

J.M. Smucker (SJM) Q4 2025 Earnings: Key financials and quarterly highlights

The J.M. Smucker Co. (NYSE: SJM) reported its fourth quarter 2025 earnings results today. Net sales was $2.1 billion, down 3% year-over-year. Comparable net sales decreased 1%. Net loss was

Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials

Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing a pipeline of product candidates with lead programs

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top